DIFFERENTIAL MODIFICATION OF OPIATE RECEPTOR ACTIVITY BY ARYLSULFATASE TREATMENT

被引：11

作者：

GARZON, J

JEN, MF

LEE, NM

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143

[2] UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143

来源：

关键词：

D O I：

10.1016/0006-2952(83)90476-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1523 / 1528

页数：6

共 25 条

[1]

CHANG KJ, 1979, J BIOL CHEM, V254, P2610

[2]

CHANG KJ, 1979, MOL PHARMACOL, V16, P91

FELDMAN, HA .

[4]

GRAY EC, 1974, J ANAT, V96, P79

[5]

LAW PY, 1979, BIOCHEM PHARMACOL, V28, P2557

[6]

LAW PY, 1978, RES COMMUN CHEM PATH, V21, P409

[7]

LITCHFIELD JT, 1949, J PHARM EXPT THERAPE, V96, P999

[8] ENDOGENOUS OPIOID PEPTIDES - MULTIPLE AGONISTS AND RECEPTORS [J].

LORD, JAH ;

WATERFIELD, AA ;

HUGHES, J ;

KOSTERLITZ, HW .

[9]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[10]

MINNEMAN KP, 1979, MOL PHARMACOL, V16, P34